Reports for NOVARTIS PHARMACEUTICALS CANADA INC
Company Name
NOVARTIS PHARMACEUTICALS CANADA INC
Shortage reports
Actual shortage:
6 (4%)
Anticipated shortage:
1 (1%)
Avoided shortage:
5 (3%)
Resolved:
158 (93%)
170
Discontinuation Reports
To be discontinued:
2 (4%)
Discontinued:
52 (96%)
Reversed:
0 (0%)
54
34 (15%)
5 (56%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-04-11 | 2022-06-17 | 158484 |
| MAXITROL | 6000UNIT 3.5MG 0.1% | SUSPENSION | Resolved | 2022-10-25 | 2023-01-25 | 172560 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-03-26 | 2018-04-13 | 44006 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-04-27 | 2018-05-25 | 47334 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2018-07-05 | 2018-07-21 | 54449 |
| NEVANAC | 0.1% | SUSPENSION | Resolved | 2019-03-21 | 2019-04-18 | 79161 |
| PATADAY | 0.2% | SOLUTION | Resolved | 2019-05-07 | 2019-06-19 | 83364 |
| PATANOL | 0.1% | LIQUID | Resolved | 2018-06-01 | 2018-06-19 | 51067 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-01-20 | 2020-03-31 | 103745 |
| PAZEO | 0.7% | SOLUTION | Resolved | 2020-05-05 | 2020-05-21 | 114100 |
| RITALIN 20MG | 20MG | TABLET | Resolved | 2017-06-07 | 2017-08-31 | 12261 |
| RITALIN-SR TAB 20MG | 20MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-05-25 | 2017-06-02 | 11280 |
| SANDOSTATIN | 50MCG | SOLUTION | Resolved | 2022-11-22 | 2023-02-11 | 175439 |
| SANDOSTATIN | 50MCG | SOLUTION | Actual shortage | 2024-03-22 | 2024-10-01 | 223074 |
| SANDOSTATIN | 100MCG | SOLUTION | Resolved | 2022-05-06 | 2023-02-11 | 160174 |
| SANDOSTATIN | 100MCG | SOLUTION | Actual shortage | 2024-02-06 | 2024-03-21 | 218624 |
| SANDOSTATIN LAR | 20MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Actual shortage | 2025-04-03 | 2025-04-15 | 254019 |
| SANDOSTATIN LAR | 30MG | POWDER FOR SUSPENSION, SUSTAINED-RELEASE | Actual shortage | 2025-04-03 | 2025-04-09 | 254013 |
| SIMULECT | 20MG | POWDER FOR SOLUTION | Resolved | 2024-07-10 | 2024-09-10 | 232638 |
| TEGRETOL | 200MG | TABLET | Resolved | 2024-08-27 | 2024-10-30 | 235974 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| AFINITOR | 7.5MG | TABLET | Discontinued | 2018-07-09 | 2018-07-10 | 54891 |
| ARZERRA | 1000MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78219 |
| ARZERRA | 100MG | SOLUTION | Discontinued | 2019-03-11 | 2019-03-12 | 78215 |
| BETOPTIC S | 0.25% | SUSPENSION | Discontinued | 2022-09-28 | 2023-01-19 | 170389 |
| BETOPTIC S | 0.25% | SUSPENSION | To be discontinued | 2025-03-11 | 2025-03-11 | 252361 |
| EXTAVIA | 0.3MG | POWDER FOR SOLUTION | Discontinued | 2022-01-12 | 2022-02-11 | 152532 |
| FLAREX | 0.1% | SUSPENSION | Discontinued | 2024-08-27 | 2024-11-28 | 235987 |
| FORADIL DRY POWDER CAPSULES FOR INHALATION | 12MCG | CAPSULE | Discontinued | 2022-10-18 | 2023-01-25 | 172087 |
| HYCAMTIN | 4MG | POWDER FOR SOLUTION | Discontinued | 2017-04-26 | 2019-06-11 | 8129 |
| ILARIS | 150MG | POWDER FOR SOLUTION | Discontinued | 2019-09-11 | 2019-09-12 | 93588 |
| ISOPTO CARPINE | 4% | LIQUID | Discontinued | 2022-05-11 | 2022-07-14 | 160361 |
| LAMISIL | 250MG | TABLET | To be discontinued | 2024-11-28 | 2024-11-28 | 244096 |
| LESCOL XL | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2020-03-20 | 2020-04-17 | 109153 |
| LIORESAL D.S. TAB 20MG | 20MG | TABLET | Discontinued | 2020-01-10 | 2020-02-24 | 103075 |
| LIORESAL INTRATHECAL 0.05MG/ML | 0.05MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201576 |
| LIORESAL INTRATHECAL 0.5MG/ML | 0.5MG | SOLUTION | Discontinued | 2023-08-17 | 2023-09-19 | 202298 |
| LIORESAL INTRATHECAL 2MG/ML | 2MG | SOLUTION | Discontinued | 2023-08-10 | 2023-09-19 | 201573 |
| LIORESAL TAB 10MG | 10MG | TABLET | Discontinued | 2020-01-10 | 2020-07-10 | 103078 |
| LOPRESOR 100MG | 100MG | TABLET | Discontinued | 2018-01-09 | 2018-01-09 | 35454 |
| LOPRESOR 50MG | 50MG | TABLET | Discontinued | 2018-01-09 | 2019-03-20 | 35419 |